Zyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by:...
FDA Recall #D-0720-2021 — Class II — June 29, 2021
Product Description
Zyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285, NDC# 0002-7597-01
Reason for Recall
cGMP deviations: Atypical appearance, decrease in size and change in color of the lyophilized cake of drug product.
Recalling Firm
Eli Lilly & Company — Indianapolis, IN
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
36,540 vials
Distribution
OH, MS, IN
Code Information
Lot # 197
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated